Analyzing Upregulated Proteins Driving Parkinson’s Disease Progression & Evaluating Their Functions as Novel Treatment-Related Biomarkers
Time: 1:30 pm
day: Pre-Conference Day
Details:
- Working with AMP PD to identify promising biomarkers of Parkinson’s disease progression
- Identifying pathways altered in Parkinson’s disease that can be remodulated to healthy levels with drug treatment
- Investigating emerging markers, such as DOPA decarboxylase, to distinguish their role as biomarkers from their function as treatment-related indicators
